Institutional Repository of Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing 100190, Peoples R China
A novel co-targeting strategy of EGFR/SEC61G for multi-modality fluorescence/MR/photoacoustic imaging of glioblastoma | |
Huang, Qi1,2,4; Wang, Kun2; Wanggou, Siyi1,4; Tian, Jie2,3; Li, Xuejun1,4 | |
发表期刊 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE |
ISSN | 1549-9634 |
2022-02-01 | |
卷号 | 40页码:11 |
通讯作者 | Tian, Jie(jie.tian@ia.ac.cn) ; Li, Xuejun(lxjneuro@csu.edu.cn) |
摘要 | Surgical resection is often the first choice and cornerstone therapy of glioblastoma; the degree of complete resection, as an important prognostic factor, is directly related to individuals' long-term outcomes. However, current imaging approaches, subjected to its single function and poor targeting affinity, used to have disappointing performance on preoperative diagnosis and intraoperative positioning. Herein, we have designed a nanoparticle for triple-modality NIF/MR/photoacoustic imaging and brought in a dual-targeting strategy with co expressed EGFR and SEC61G in glioblastoma. In comparison with the dual-negative nanocarrier, the EGFR/SEC61G biotargeting nanoprobe presented a significantly enhanced contrast and durability in vivo. Furthermore, we have evaluated the safety and biocompatibility using a CCK-8 assay ex vivo, which showed negligible toxicity. Therefore, the dual-target probes hold great potentials for a comprehensive preoperative plan and durable intraoperative navigation in glioblastoma.(c) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/). |
关键词 | Glioblastoma Multi-modality Molecular imaging Dual-target Theranostic |
DOI | 10.1016/j.nano.2021.102509 |
关键词[WOS] | CENTRAL-NERVOUS-SYSTEM ; 5-AMINOLEVULINIC ACID ; BRAIN ; RESECTION ; GLIOMA ; NANOPARTICLES ; EXTENT ; GENE ; ENDOCYTOSIS ; DELIVERY |
收录类别 | SCI |
语种 | 英语 |
资助项目 | National Natural Science Foundation of China[81770781] ; National Natural Science Foundation of China[61671449] ; National Natural Science Foundation of China[81227901] ; National Natural Science Foundation of China[8193053] ; Key Research and Development Program of Hunan Province, China[2020SK2062] ; Chinese Academy of Sciences[QYZDJ-SSW-JSC005] ; Chinese Academy of Sciences[YJKYYQ20180048] ; Special funds for innovition in Hunan Province[2020SK2062] ; Science Foundation of Hunan Province, China[2019JJ50978] ; Xiangya big data platform |
项目资助者 | National Natural Science Foundation of China ; Key Research and Development Program of Hunan Province, China ; Chinese Academy of Sciences ; Special funds for innovition in Hunan Province ; Science Foundation of Hunan Province, China ; Xiangya big data platform |
WOS研究方向 | Science & Technology - Other Topics ; Research & Experimental Medicine |
WOS类目 | Nanoscience & Nanotechnology ; Medicine, Research & Experimental |
WOS记录号 | WOS:000806835000004 |
出版者 | ELSEVIER |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.ia.ac.cn/handle/173211/49633 |
专题 | 中国科学院分子影像重点实验室 |
通讯作者 | Tian, Jie; Li, Xuejun |
作者单位 | 1.Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Peoples R China 2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China 3.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing, Peoples R China 4.Cent South Univ, Xiangya Hosp, Hunan Int Sci & Technol Cooperat Base Brain Tumor, Changsha, Hunan, Peoples R China |
第一作者单位 | 中国科学院自动化研究所 |
通讯作者单位 | 中国科学院自动化研究所 |
推荐引用方式 GB/T 7714 | Huang, Qi,Wang, Kun,Wanggou, Siyi,et al. A novel co-targeting strategy of EGFR/SEC61G for multi-modality fluorescence/MR/photoacoustic imaging of glioblastoma[J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE,2022,40:11. |
APA | Huang, Qi,Wang, Kun,Wanggou, Siyi,Tian, Jie,&Li, Xuejun.(2022).A novel co-targeting strategy of EGFR/SEC61G for multi-modality fluorescence/MR/photoacoustic imaging of glioblastoma.NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE,40,11. |
MLA | Huang, Qi,et al."A novel co-targeting strategy of EGFR/SEC61G for multi-modality fluorescence/MR/photoacoustic imaging of glioblastoma".NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 40(2022):11. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论